Anthelmintic Potential of Vernonia amygdalina on Toxocara canis in Domesticated Dogs
Biotechnology Journal International · pp. 43–51 · Published 6 Nov 2023
10.9734/bji/2023/v27i6705Abstract
Toxocariasis is a worldwide zoonotic parasitic infection and one route of preventing the disease in dogs and subsequent transmission to humans, especially children, is through treatment with anthelmintic. A study aimed at assessing the anthelmintic efficacy of Vernonia amygdalina leaves extract on Toxocara canis in domesticated dogs was carried out where the proximate and phytochemical components of the leaf extract were determined using the standard method and Gas Chromatography-Mass Spectrometry, the anthelmintic efficacy was assessed in vitro and in vivo respectively. The study revealed that this plant contained alkaloids, saponins, tannins, glycosides, flavonoids, terpenoids, phenol and steroids. Lethal concentration (LC50) of 14.83ml/mg at 12 hours and a percentage egg reduction of 84% after 2 weeks was recorded, which revealed that the plant leaves have anthelmintic potential and this could be attributed to the presence of flavonoids which are associated with the treatment of gastric infections and also n-Hexadecanoic acid which accounts for it anthelmintic (nematicidal) effect, alongside Octadecanoic acid which is an anti-inflammatory compound.
Cited by 0
No indexed citations yet.
Related research
- A Randomized Placebo Controlled Study to Determine the Efficacy of Oral Diclofenac Sodium in the Treatment of Symptomatic Osteoarthritis of the Knee in Nnewi, South Eastern Nigeria — shares topic coverage
- Bacteriological and Fungal Evaluation of Three Brands of Disinfectants Sold in Calabar Municipality, Cross River State — shares topic coverage
- Drug Interactions, Safety and Efficacy of Probiotics — shares topic coverage
- The Efficacy of the Volume of Hyperbaric Bupivacaine Used and Its Influence on Spinal Anaesthesia Induced Hypotension during Caesarean Section — shares topic coverage
- A Comparison of Efficacy of Two Brands of Enoxaparin in COVID-19 Patients: A Pilot Study — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.